Zobrazeno 1 - 10
of 45
pro vyhledávání: '"S. Gorbatenko"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 6, Pp 831-836 (2022)
Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular atrial fibrillation (AF) in real clinical practice, to evaluate changes of prescriptions from 2012 till 2020.Material and methods. The medical records of i
Externí odkaz:
https://doaj.org/article/3102dcb707274aca9d12d6a303d81992
Autor:
N. D. Bunyatyan, V. I. Petrov, O. V. Shatalova, A. V. Ponomareva, A. Yu. Ryazanova, V. S. Gorbatenko, A. S. Gerasimenko, E. A. Sokova
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 11, Iss 4, Pp 239-245 (2021)
Infectious process is an important cause of morbidity and mortality among patients with chronic kidney disease. Prescription of antibacterial drugs should take into account the pharmacokinetic parameters of the medicine and the individual characteris
Externí odkaz:
https://doaj.org/article/e4da436c05b849638a5480b5fb13fb30
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 2, Pp 303-309 (2021)
Intracerebral hemorrhage (ICH) is severe and fatal complication of anticoagulant therapy with an incidence 0.3-0.7% per year. For patients with atrial fibrillation (AF) anticoagulants are administered for decreasing risk of stroke and systemic emboli
Externí odkaz:
https://doaj.org/article/c78a7b27abc04058be9a89d06886e589
Autor:
V. I. Petrov, A. A. Amosov, A. S. Gerasimenko, O. V. Shatalova, A. V. Ponomareva, A. N. Akinchits, I. S. Kulakova, V. S. Gorbatenko
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 8, Iss 6, Pp 380-391 (2021)
The development of a "cytokine storm", characteristic of severe COVID-19 forms, can be defined as a state of uncontrolled release of a large number of inflammatory mediators.The attachment of SARS-CoV-2 S-glycoprotein to angiotensin-converting enzyme
Externí odkaz:
https://doaj.org/article/2d817332f3da480e8899616bd062a988
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 8, Iss 4, Pp 222-232 (2021)
Background. Every fifth ischemic stroke is caused by a patient’s history of atrial fibrillation. Nowadays, direct and indirect oral anticoagulants are widely used to prevent thromboembolic complications in patients with atrial fibrillation. However
Externí odkaz:
https://doaj.org/article/f03316344da642268904b5ab73386601
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 4, Pp 530-537 (2019)
The purpose of this review is to examine the possibilities and prospects for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with atrial fibrillation and chronic kidney disease. Chronic kidney dise
Externí odkaz:
https://doaj.org/article/32ecd17577f94f39bd462e8c2d523967
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 1, Pp 49-53 (2019)
Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular atrial fibrillation (AF) who were hospitalized in the cardiology department of a multidisciplinary hospital.Material and methods. A retrospective one-time
Externí odkaz:
https://doaj.org/article/5aacaab3d4e542849d631bb1729a688c
Autor:
Elena I. Sinauridze, Alexander S. Gorbatenko, Elena A. Seregina, Elena N. Lipets, Fazoil I. Ataullakhanov
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract Artificial plasma expanders (PEs) are widely used in modern transfusion medicine. PEs do not contain components of the coagulation system, so their infusion in large volumes causes haemodilution and affects haemostasis. However, the existing
Externí odkaz:
https://doaj.org/article/cabeb134f4034f4e806afaa83c3cc50a
Autor:
O. V. Shatalova, V. S. Gorbatenko
Publikováno v:
Современная ревматология, Vol 11, Iss 2, Pp 25-29 (2017)
Objective: to evaluate the efficacy of tocilizumab (TCZ) versus tofacitinib (TOFA) in patients with severe and moderate rheumatoid arthritis (RA) who have not previously received methotrexate (MTX). Material and methods. A systematic search for studi
Externí odkaz:
https://doaj.org/article/c5222bf359004959b51e22fffcb1fef9
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 6, Pp 31-39 (2017)
Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management of venous thromboembolism (VTE).Material and methods. This meta-analysis of randomized controlled trials (RCTs) was made in accordance with the instruct
Externí odkaz:
https://doaj.org/article/b1fdaca0c24349efb3189f8c77299c99